Head and Neck Cancer Clinical Trials in Fuzhou
2 recruitingFuzhou, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Head and Neck CancerNasopharyngeal CarcinomaBiomarker+1 more
Nanfang Hospital, Southern Medical University300 enrolled5 locationsNCT06307314